← Back
$XERS All transactions

Xeris Biopharma Holdings, Inc.

F

$ Value

$489K

Shares

66,450

Price

$7

Filed

Feb 2

Insider

Name

Pieper Steven

Title

See Remarks

CIK

0001875714

Roles

Officer

Transaction Details

Transaction Date

2026-01-31

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,394,332

Footnotes

These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the "Plan"). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued employment through such vesting date. | Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026. | These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service through such vesting date.

Filing Info

Accession No.

0001875714-26-000002

Form Type

4

Issuer CIK

0001867096

Pieper Steven's History

Date Ticker Type Value
2026-03-05 XERS M $114K
2026-03-05 XERS M $83K
2026-03-05 XERS M $0
2026-03-05 XERS M $0
2026-01-31 XERS F $823K
2026-01-31 XERS F $489K
2026-01-31 XERS F $201K
2026-01-30 XERS A $0
2026-01-30 XERS A $0

Other Insiders at XERS (90d)

Insider Bought Sold Last
Shannon John Patrick Jr
See Remarks
2026-01-31
Hecht Beth
See Remarks
$328K 2026-04-01
Pieper Steven
See Remarks
2026-03-05
Brady James Aloysius $60K 2026-03-30
McCulloch Kevin
See Remarks
2026-03-12
Nguyen Anh Tu
See Remarks
2026-02-24